advisorsecurities master

LEGNLegend Biotech Corporation American Depositary Shares

ADRCNasdaq (XNAS)·USD

Identity

Security key
17976
Ticker
LEGN
Type
ADRCAmerican Depository Receipt Common
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2020-06-05
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
LEGN

Detail

Enriched 2026-08-14 20:47

Market cap
$4,001,339,390.3
Shares outstanding (class)
185,739,792
Shares outstanding (weighted)
193,769,462
SIC
Employees
3,100
Location
Description

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data